- Home
- WST vs IP Comparison
WST vs IP Comparison
Compare WST & IP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- IP
- Stock Information
- Founded
- WST 1923
- IP 1898
- Country
- WST United States
- IP United States
- Employees
- WST N/A
- IP N/A
- Industry
- WST Medical/Dental Instruments
- IP Paper
- Sector
- WST Health Care
- IP Basic Materials
- Exchange
- WST Nasdaq
- IP Nasdaq
- Market Cap
- WST 15.2B
- IP N/A
- IPO Year
- WST N/A
- IP N/A
- Fundamental
- Price
- WST $213.06
- IP $44.26
- Analyst Decision
- WST Strong Buy
- IP Strong Buy
- Analyst Count
- WST 6
- IP 9
- Target Price
- WST $349.00
- IP $54.63
- AVG Volume (30 Days)
- WST 977.3K
- IP 4.1M
- Earning Date
- WST 04-24-2025
- IP 04-30-2025
- Dividend Yield
- WST 0.39%
- IP 4.18%
- EPS Growth
- WST N/A
- IP 116.33
- EPS
- WST 6.37
- IP 1.05
- Revenue
- WST $2,895,800,000.00
- IP $19,901,000,000.00
- Revenue This Year
- WST $1.24
- IP $50.05
- Revenue Next Year
- WST $6.56
- IP $5.03
- P/E Ratio
- WST $33.62
- IP $42.19
- Revenue Growth
- WST N/A
- IP 7.49
- 52 Week Low
- WST $187.43
- IP $38.10
- 52 Week High
- WST $372.79
- IP $60.36
- Technical
- Relative Strength Index (RSI)
- WST 48.76
- IP 40.19
- Support Level
- WST $204.79
- IP $43.56
- Resistance Level
- WST $221.42
- IP $45.56
- Average True Range (ATR)
- WST 7.01
- IP 1.44
- MACD
- WST 1.16
- IP 0.01
- Stochastic Oscillator
- WST 56.77
- IP 14.73
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.